| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |